US Stock MarketDetailed Quotes

STOK Stoke Therapeutics

Watchlist
  • 14.280
  • -0.300-2.06%
Close Jul 24 16:00 ET
744.28MMarket Cap-5900P/E (TTM)

About Stoke Therapeutics Company

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Company Profile

SymbolSTOK
Company NameStoke Therapeutics
Listing DateJun 19, 2019
Issue Price18.00
Founded2014
CEODr. Edward M. Kaye, M.D.
MarketNASDAQ
Employees110
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address45 Wiggins Avenue
CityBedford
ProvinceMassachusetts
CountryUnited States of America
Zip Code01730
Phone1-781-430-8200

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Edward M. Kaye, M.D.
  • Chief Executive Officer and Director
  • 3.53M
  • Dr. Huw M. Nash, PhD
  • Chief Business Officer
  • --
  • Barry S. Ticho, M.D.,PhD
  • Chief Medical Officer
  • 1.65M
  • Thomas Leggett
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Seth L. Harrison, M.D.
  • Chairman of the Board
  • 237.33K
  • Dr. Garry E. Menzel, PhD
  • Independent Director
  • 199.33K
  • Dr. Arthur A. Levin,PhD
  • Independent Director
  • 198.33K
  • Julie Anne Smith
  • Independent Director
  • 206.83K
  • Dr. Arthur O. Tzianabos, PhD
  • Independent Director
  • 211.83K
  • Professor Adrian R. Krainer, PhD
  • Independent Director
  • 198.33K
  • Jennifer C. Burstein, C.P.A.
  • Independent Director
  • 209.33K
  • Ian F. Smith
  • Independent Director
  • 394.03K
  • Jonathan Allan
  • General Counsel and Corporate Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg